Table 2 Relationship between each gene and clinical outcomes in Colombia
| Â | Total | Â | gastritis | Â | DU | Â | Â | GC | Â | Â |
|---|---|---|---|---|---|---|---|---|---|---|
n | 174 | Â | 68 | Â | 43 | Â | P | 63 | Â | P |
mean age | 53.4 ± 16.4 |  | 52.0 ± 16.5 |  | 48.4 ± 15.9 |  | 0.50 | 58.1 ± 15.5 |  | 0.01 |
male | 90 | (50.8%) | 28 | (40.6%) | 22 | (50.0%) | 0.30 | 40 | (62.5%) | 0.01 |
cagA | 116 | (65.5%) | 44 | (63.8%) | 27 | (61.4%) | 0.83 | 45 | (70.3%) | 0.41 |
vacA s1 | 136 | (76.8%) | 50 | (72.5%) | 33 | (75.0%) | 0.70 | 54 | (84.4%) | 0.08 |
vacA m1 | 111 | (62.7%) | 38 | (55.1%) | 26 | (59.1%) | 0.63 | 48 | (75.0%) | 0.01 |
hp0967 | 85 | (48.0%) | 33 | (47.8%) | 20 | (45.5%) | 0.83 | 32 | (50.0%) | 0.79 |
jhp0045 | 42 | (23.7%) | 14 | (20.3%) | 13 | (29.5%) | 0.24 | 15 | (23.4%) | 0.65 |
jhp0046 | 50 | (28.2%) | 18 | (26.1%) | 15 | (34.1%) | 0.34 | 17 | (26.6%) | 0.94 |
jhp0951 | 102 | (57.6%) | 40 | (58.0%) | 26 | (59.1%) | 0.86 | 36 | (56.3%) | 0.84 |